UNSPSC 51162304: Acetaminophen/brompheniramine/pseudoephedrine

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE599. This VA Drug Class (RE599) classifies this compound as belonging to the group COLD REMEDIES, OTHER.

The first component of this combination drug is an analgesic and antipyretic with the molecular formula C8H9NO2, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier 362O9ITL9D, chemically known as n-(4-hydroxyphenyl)acetamide but more generally known as acetaminophen, which bears U.S. National Institutes of Health Compound Identifier 1983. Acetaminophen comes in many forms, including base, acetate, cysteine, cysteinylglycine, di-methyl derivative, glucuronide, glutathione, hemisuccinate, mercapturate, and sulfate.

UNSPSC 51162304 Acetaminophen/brompheniramine/pseudoephedrine is a Commodity code that captures state and local procurement of pharmaceutical products and related healthcare supplies, though recent activity under this code reflects a broader scope of parenteral and emergency medical products than the code name alone suggests. State and local buyers under this code include state correctional departments and county health agencies, which procure prescription and over-the-counter medications, intravenous solutions, and emergency medical supplies to support incarcerated populations and community health initiatives. The Washington State Department of Corrections and Seminole County, Florida represent the issuing-body types active in this space—a state agency managing healthcare delivery across correctional facilities and a county health authority sourcing emergency medical supplies. Scope requirements include documented experience preparing and delivering pharmaceutical products on tight timelines, compliance with state business licensure and background-clearance standards, and maintenance of commercial general liability, professional liability, and cyber liability insurance.

Recent activity centers on the Pacific Northwest and Southeast. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, due October 7, 2026, for parenteral products, services, and equipment—including TPN and PPN solutions, intravenous solutions, and controlled substances—to supply eight correctional facilities across Washington state, with an initial contract term running November 26, 2026 through June 30, 2030, and multiple contractor awards anticipated (up to three per region). The solicitation includes set-asides and aspirational goals for small businesses (25%), minority-owned businesses (10%), women-owned businesses (6%), and veteran-owned businesses (5%), with a Subcontractor Inclusion Plan requirement. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, due July 26, 2023, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, under an initial two-year term with one-year renewal option.